ISRCTN97344827已完成未知
A randomised trial to evaluate early high dose therapy and autologous bone marrow transplantation as part of planned initial therapy for poor risk intermediate/high grade non-Hodgkin's lymphoma
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
- 2010 results in https://doi.org/10.1111/j.1365-2141.2010.08081.x (added 25/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 16-65 years
- •2. No medical conditions other than lymphoma, prohibiting intensive therapy. No systemic treatment for cancer in the previous 5 years
- •3. Histology: Follicular large cell lymphoma; Diffuse mixed cell lymphoma; Diffuse large cell lymphoma; Diffuse immunoblastic lymphoma
- •4. Full clinical staging to include Computed Tomography (CT) scanning of abdomen and bone marrow trephine biopsy
- •5. Poor prognostic features, defined as the presence of two or three of: Stage III or IV; Lactic dehydrogenase (LDH) > normal; Performance status 2-4 (Eastern Cooperative Oncology Group [ECOG]-World Health Organisation [WHO])
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
1 期
Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular DystrophyBecker Muscular DystrophyNCT04386304Epirium Bio Inc.22
已完成
不适用
Evaluation of early and combined treatment with surfactant and inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertensioeonatal hypoxic respiratory failure and pulmonary hypertensionNeonatal DiseasesISRCTN13727958Pontificia Universidad Católica de Chile100
招募中
1 期
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic NeoplasmsLeukemia, Myeloid, AcuteMyelodysplastic NeoplasmsNCT06651229Janssen Research & Development, LLC155
招募中
1 期
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)NCT05885412Rocket Pharmaceuticals Inc.9
终止
1 期
Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH DeficiencyPhenylketonuriasPAH DeficiencyPhenylketonuriaNCT05222178Homology Medicines, Inc3